(Q40827715)

24 September 2017

title

Emerging standardization in pharmacoeconomics (English)

1 reference

24 September 2017

Mullins CD

1

1 reference

24 September 2017

Ogilvie S

series ordinal

2

1 reference

24 September 2017

publication date

1 November 1998

1 reference

24 September 2017

published in

Clinical Therapeutics

1 reference

24 September 2017

volume

20

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

1194-202; discussion 1192-3

1 reference

Methods of cost-effectiveness analysis: areas of consensus and debate

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

Making economic evaluations respectable

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

Economic evaluation under managed competition: evidence from the U.K.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

From Principle To Public Policy: Using Cost-Effectiveness Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980115-X

7 January 2021

10.1016/S0149-2918(98)80115-X

Identifiers

DOI

1 reference

24 September 2017

1 reference